ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1

The Integrin Very Late Antigen-4 Plays a Key Role in the Recruitment of B Cells at the Inflammatory Foci

Estefanía Armas-González1, Ana Díaz-Martín2, María Jesús Domínguez-Luis3, María Teresa Arce-Franco2 and Federico Díaz-González4, 1Universidad de La Laguna, Pharmacology Department, Tenerife, Spain, 2Hospital Universitario de Canarias, Rheumatology Service, Tenerife, Spain, 3CIBICAN, Center of Biomedical Research of the Canary Islands, University of La Laguna, Tenerife, Spain, 4Investigation Unit, Sociedad Española de Reumatológía, Madrid, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adhesion molecules, B cells, Cell Migration, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Experimental data suggest that B cells must migrate and accumulate into the synovial membrane to exert their pathogenic role in rheumatoid arthritis (RA). Leukocyte extravasation requires a number of coordinated adhesives events between circulating leukocytes and endothelial cells, a process known as the adhesion cascade. While the molecules involved in the sequential steps of the adhesion cascade for neutrophils and T lymphocytes have been well established, little is known about this process in B cells. 

Objective: To determine the adhesion molecules involved in the interactions between B cells and endothelium under dynamic condition resembling those of postcapillary venules during the inflammatory response. 

Methods:

The surface expression levels of very late antigen (VLA)-4, intercellular adhesion molecule (ICAM)-1 and L-selectin were assessed by double-colour staining flow cytometry analysis in CD20 + cells from the peripheral blood (PB) and synovial fluid (SF), simultaneously obtained from 10 RA and 8 psoriatic arthritis (PsA) patients. Dynamic interactions between B cells negatively immunoselected from buffy coats, and 12h TNF-a-activated human umbilical vein endothelial cell (HUVEC) monolayers were studied in a two-parallel plate flow chamber. To study molecules involved in the B-cells-HUVEC dynamic interaction, B cells were preincubated with monoclonal antibodies (mAbs) anti-CD20 or blocking mAbs anti- L-selectin, VLA-4 and ICAM-1; and HUVEC, with anti-vascular adhesion molecule (VCAM)-1.

Results:

Flow cytometry analysis showed that the VLA-4 surface expression level in B-cells from SF in both RA (105±30%) and PsA (135±45%) patients was not significantly different with respect to PB (considered 100%). Interestingly, the surface expression level of ICAM-1 was significantly higher in SF relative to PB, in both RA (280±85%;) and PsA (300±65%) patients, while L-selectin surface expression diminished in SF compared to PB in RA (40±5%) and PsA (45±5%). In flow chamber experiments, no differences were observed in the process of rolling when B cells were incubated with anti-CD20 antibodies, or with blocking mAbs anti-L-selectin and anti-ICAM-1 with respect to cells incubated with mAb matching controls. However, the presence of blocking anti-VLA-4 mAb or anti-VCAM-1 mAbs abrogated the interaction of B cells with activated endothelial cells.

Conclusion:

These results suggest that 1) B-cells with increased ICAM-1 expression and decreased L-selectin expression are preferentially recruited in the inflamed synovial microenvironment; and 2) the integrin VLA-4, vis-à-vis its endothelial counter receptor VCAM-1, plays a key role in the initial process of B-cell extravasation to inflammatory foci.


Disclosure: E. Armas-González, None; A. Díaz-Martín, None; M. J. Domínguez-Luis, None; M. T. Arce-Franco, None; F. Díaz-González, None.

To cite this abstract in AMA style:

Armas-González E, Díaz-Martín A, Domínguez-Luis MJ, Arce-Franco MT, Díaz-González F. The Integrin Very Late Antigen-4 Plays a Key Role in the Recruitment of B Cells at the Inflammatory Foci [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-integrin-very-late-antigen-4-plays-a-key-role-in-the-recruitment-of-b-cells-at-the-inflammatory-foci/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-integrin-very-late-antigen-4-plays-a-key-role-in-the-recruitment-of-b-cells-at-the-inflammatory-foci/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology